Cargando…
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Monoclonal IgG antibodies are the fastest growing class of biologics, but large differences exist in their plasma half-life in humans. Thus, to design IgG antibodies with favorable pharmacokinetics, it is crucial to identify the determinants of such differences. Here, we demonstrate that the variabl...
Autores principales: | Grevys, Algirdas, Frick, Rahel, Mester, Simone, Flem-Karlsen, Karine, Nilsen, Jeannette, Foss, Stian, Sand, Kine Marita Knudsen, Emrich, Thomas, Fischer, Jens Andre Alexander, Greiff, Victor, Sandlie, Inger, Schlothauer, Tilman, Andersen, Jan Terje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800109/ https://www.ncbi.nlm.nih.gov/pubmed/35118359 http://dx.doi.org/10.1016/j.isci.2022.103746 |
Ejemplares similares
-
Human and mouse albumin bind their respective neonatal Fc receptors differently
por: Nilsen, Jeannette, et al.
Publicado: (2018) -
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2022) -
An intact C-terminal end of albumin is required for its long half-life in humans
por: Nilsen, Jeannette, et al.
Publicado: (2020) -
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
por: Grevys, Algirdas, et al.
Publicado: (2018) -
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics
por: Sand, Kine Marita Knudsen, et al.
Publicado: (2015)